The challenge for NIH ethics policies: Preserving public trust and biomedical progress

Article Type
Changed
Tue, 09/25/2018 - 14:49
Display Headline
The challenge for NIH ethics policies: Preserving public trust and biomedical progress
Article PDF
Author and Disclosure Information

Norka Ruiz Bravo, PhD
Deputy Director for Extramural Research, National Institutes of Health, Bethesda, MD

Correspondence: Norka Ruiz Bravo, PhD, NIH Deputy Director for Extramural Research, National Institutes of Health, One Center Drive, Building One, Room 150, Bethesda, MD 20892; ruizbran@od.nih.g

Dr. Ruiz Bravo reported that she has no financial interests, relationships, or affiliations that pose a potential conflict of interest with this article.

Publications
Page Number
S29-S31
Author and Disclosure Information

Norka Ruiz Bravo, PhD
Deputy Director for Extramural Research, National Institutes of Health, Bethesda, MD

Correspondence: Norka Ruiz Bravo, PhD, NIH Deputy Director for Extramural Research, National Institutes of Health, One Center Drive, Building One, Room 150, Bethesda, MD 20892; ruizbran@od.nih.g

Dr. Ruiz Bravo reported that she has no financial interests, relationships, or affiliations that pose a potential conflict of interest with this article.

Author and Disclosure Information

Norka Ruiz Bravo, PhD
Deputy Director for Extramural Research, National Institutes of Health, Bethesda, MD

Correspondence: Norka Ruiz Bravo, PhD, NIH Deputy Director for Extramural Research, National Institutes of Health, One Center Drive, Building One, Room 150, Bethesda, MD 20892; ruizbran@od.nih.g

Dr. Ruiz Bravo reported that she has no financial interests, relationships, or affiliations that pose a potential conflict of interest with this article.

Article PDF
Article PDF
Page Number
S29-S31
Page Number
S29-S31
Publications
Publications
Article Type
Display Headline
The challenge for NIH ethics policies: Preserving public trust and biomedical progress
Display Headline
The challenge for NIH ethics policies: Preserving public trust and biomedical progress
Citation Override
Cleveland Clinic Journal of Medicine 2007 March;74(suppl 2):S29-S31
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Guiding principles: Where are we headed?

Article Type
Changed
Tue, 09/25/2018 - 14:49
Display Headline
Guiding principles: Where are we headed?
Panel discussion
Article PDF
Author and Disclosure Information

Moderator
Nina Totenberg

Legal Affairs Correspondent, National Public Radio, Washington, DC

Panelists
Darrell G. Kirch, MD

President and CEO, Association of American Medical Colleges, Washington, DC

Paul A. LaViolette, MBA
Chief Operating Officer, Boston Scientific Corporation, Natick, MA; Member, Board of Directors, and Chairman, Special Committee on Codes of Ethics, AdvaMed

Norka Ruiz Bravo, PhD
Deputy Director for Extramural Research, National Institutes of Health, Bethesda, MD

Mr. LaViolette reported that he has no financial interests or relationships that pose a potential conflict of interest with this article apart from his employment with Boston Scientific Corp., from which he receives a salary and in which he holds ownership interest.

All other participants reported that they have no financial interests, relationships, or affiliations that pose a potential conflict of interest with this article.

 

Publications
Page Number
S32-S37
Author and Disclosure Information

Moderator
Nina Totenberg

Legal Affairs Correspondent, National Public Radio, Washington, DC

Panelists
Darrell G. Kirch, MD

President and CEO, Association of American Medical Colleges, Washington, DC

Paul A. LaViolette, MBA
Chief Operating Officer, Boston Scientific Corporation, Natick, MA; Member, Board of Directors, and Chairman, Special Committee on Codes of Ethics, AdvaMed

Norka Ruiz Bravo, PhD
Deputy Director for Extramural Research, National Institutes of Health, Bethesda, MD

Mr. LaViolette reported that he has no financial interests or relationships that pose a potential conflict of interest with this article apart from his employment with Boston Scientific Corp., from which he receives a salary and in which he holds ownership interest.

All other participants reported that they have no financial interests, relationships, or affiliations that pose a potential conflict of interest with this article.

 

Author and Disclosure Information

Moderator
Nina Totenberg

Legal Affairs Correspondent, National Public Radio, Washington, DC

Panelists
Darrell G. Kirch, MD

President and CEO, Association of American Medical Colleges, Washington, DC

Paul A. LaViolette, MBA
Chief Operating Officer, Boston Scientific Corporation, Natick, MA; Member, Board of Directors, and Chairman, Special Committee on Codes of Ethics, AdvaMed

Norka Ruiz Bravo, PhD
Deputy Director for Extramural Research, National Institutes of Health, Bethesda, MD

Mr. LaViolette reported that he has no financial interests or relationships that pose a potential conflict of interest with this article apart from his employment with Boston Scientific Corp., from which he receives a salary and in which he holds ownership interest.

All other participants reported that they have no financial interests, relationships, or affiliations that pose a potential conflict of interest with this article.

 

Article PDF
Article PDF
Panel discussion
Panel discussion
Page Number
S32-S37
Page Number
S32-S37
Publications
Publications
Article Type
Display Headline
Guiding principles: Where are we headed?
Display Headline
Guiding principles: Where are we headed?
Citation Override
Cleveland Clinic Journal of Medicine 2007 March;74(suppl 2):S32-S37
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Wed, 08/01/2018 - 08:45
Un-Gate On Date
Wed, 08/01/2018 - 08:45
Use ProPublica
CFC Schedule Remove Status
Wed, 08/01/2018 - 08:45
Article PDF Media